Berkshire Hathaway’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-42,789,295
| Closed | -$417M | – | 46 |
|
|
2021
Q3 | $417M | Hold |
42,789,295
| – | – | 0.14% | 30 |
|
|
2021
Q2 | $424M | Hold |
42,789,295
| – | – | 0.14% | 32 |
|
|
2021
Q1 | $494M | Hold |
42,789,295
| – | – | 0.18% | 32 |
|
|
2020
Q4 | $413M | Hold |
42,789,295
| – | – | 0.15% | 35 |
|
|
2020
Q3 | $386M | Hold |
42,789,295
| – | – | 0.16% | 33 |
|
|
2020
Q2 | $528M | Hold |
42,789,295
| – | – | 0.26% | 26 |
|
|
2020
Q1 | $384M | Sell |
42,789,295
-460,000
| -1% | -$4.13M | 0.22% | 31 |
|
|
2019
Q4 | $424M | Hold |
43,249,295
| – | – | 0.18% | 39 |
|
|
2019
Q3 | $298M | Hold |
43,249,295
| – | – | 0.14% | 40 |
|
|
2019
Q2 | $399M | Hold |
43,249,295
| – | – | 0.19% | 39 |
|
|
2019
Q1 | $678M | Hold |
43,249,295
| – | – | 0.34% | 31 |
|
|
2018
Q4 | $667M | Hold |
43,249,295
| – | – | 0.36% | 31 |
|
|
2018
Q3 | $932M | Hold |
43,249,295
| – | – | 0.42% | 27 |
|
|
2018
Q2 | $1.05B | Buy |
43,249,295
+2,709,585
| +7% | +$65.9M | 0.54% | 23 |
|
|
2018
Q1 | $693M | Buy |
40,539,710
+21,663,989
| +115% | +$370M | 0.37% | 30 |
|
|
2017
Q4 | $358M | Buy |
+18,875,721
| New | +$358M | 0.19% | 35 |
|